Back to top
more

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$237.84 USD

237.84
1,032,669

+0.54 (0.23%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $237.77 -0.07 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

What's in Store for Henry Schein (HSIC) in Q3 Earnings?

Strengthening demand in the global dental and medical markets along with the recent investments are likely to have contributed to Henry Schein's (HSIC) Q3 performance.

Can Becton Dickinson (BDX) Keep the Earnings Surprise Streak Alive?

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

SmileDirectClub (SDC) Introduces Two New Water Flossers

SmileDirectClub (SDC) launched the new Large Tank and Compact Water Flossers, currently available at Shop.SmileDirectClub.com, Amazon, Walmart and Walmart.com.

Zacks.com featured highlights include: Becton, Dickinson and Co, Ternium and AutoNation

Zacks.com featured highlights include: Becton, Dickinson and Co, Ternium and AutoNation

QIAGEN's (QGEN) New Manchester Facility to Fortify UK Foothold

QIAGEN's (QGEN) new campus is expected to bring the benefits of transformational molecular diagnostics to Manchester and the global healthcare market.

Tirthankar Chakraborty headshot

3 Must-Buy Efficient Stocks to Boost Portfolio Returns

Becton, Dickinson and Company (BDX), Ternium (TX) & AutoNation (AN) are three must-buy efficient stocks that can enrich your portfolio now.

BDX or MMSI: Which Is the Better Value Stock Right Now?

BDX vs. MMSI: Which Stock Is the Better Value Option?

Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?

Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).

Intuitive Surgical (ISRG) Q3 Earnings Match Estimates, Up Y/Y

Intuitive Surgical's (ISRG) third-quarter results reflect strong segmental performance.

The Zacks Analyst Blog Highlights: Oracle, Lowe's, Starbucks, Goldman Sachs and Becton, Dickinson and Co

The Zacks Analyst Blog Highlights: Oracle, Lowe's, Starbucks, Goldman Sachs and Becton, Dickinson and Co

Sheraz Mian headshot

Top Stock Reports for Oracle, Lowe's & Starbucks

Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Lowe's Companies, Inc. (LOW), and Starbucks Corporation (SBUX).

Here's Why You Should Invest In Henry Schein (HSIC) Now

Investors continue to be optimistic about Henry Schein (HSIC) on its extensive global foothold and raised 2021 earnings guidance.

PerkinElmer (PKI) Receives EUA from FDA for Latest Assay

PerkinElmer's (PKI) latest test receives EUA from the FDA, thereby enabling qualified laboratories to detect and differentiate SARS-CoV-2, influenza A, influenza B and RSV.

BD's (BDX) New Manufacturing Facility to Boost Supply Readiness

BD's (BDX) latest manufacturing line is expected to not only boost supply capacity but also provide priority access to needles and syringes to the U.S. government.

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

BD's (BDX) Rotarex Atherectomy System receives expanded 510 (k) clearance from the FDA that can help in the treatment of in-stent restenosis in the United States.

Hologic (HOLX) Launches Novodiag System for On-Demand Testing

Hologic (HOLX) introduces the Novodiag system in Europe for on-demand testing of infectious diseases and antimicrobial resistance.

Tesla, Becton, Dickinson and Co, Computer Programs and Systems, AutoNation and Paycom Software highlighted as Zacks Bull and Bear of the Day

Tesla, Becton, Dickinson and Co, Computer Programs and Systems, AutoNation and Paycom Software highlighted as Zacks Bull and Bear of the Day

Brian Bolan headshot

Bear Of The Day: Becton, Dickinson and Co (BDX)

Despite a beating the number in the most recent report, this stock has fallen to the lowest Zacks Rank

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Add Omnicell (OMCL) to Your Portfolio

Investors continue to be optimistic about Omnicell (OMCL) on its strategic acquisitions and partnerships supporting each of the three legs of its strategy.

Debanjana Dey headshot

Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.

BD's (BDX) Latest Diagnostic System to Improve Lab Efficiency

BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.

BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA

EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Add Omnicell (OMCL) to Your Portfolio

Omnicell (OMCL) ended the second quarter with better-than-expected results, with the top line registering solid year-over-year growth.